Abstract
We carried out the clinical validation of pathogenetically substantiated protocols for the treatment of female dogs with tumour lesions of the mammary gland. The positive effect of corrective therapy was characterized by a decrease in the physiological level of fibrinogen: in benign tumours in 10 days, malignant – in 14 days against the background of its stable high level in control animals with malignant neoplasia. In the postoperative period in experimental animals, the functioning of the internal coagulation unit was restored, as evidenced by the normalization of the activated partial thromboplastin time for benign tumours by days 10–14, malignant – by 14 days. In control patients, these changes were detected only for benign neoplasms. Shifts of the external mechanism of blood coagulation in the experimental groups were eliminated in benign neoplasia cases in 10 days, malignant cases in 14 days against the background of severe disorders in this link in control patients throughout the observation period. The positive effect of complex treatment regimens is confirmed by the restoration of total fibrinolytic activity by days 10–14 due to the normalization in the same terms of the plasminogen activator and tissue plasminogen activator by days 3–7. In control animals, the total fibrinolytic activity was consistent with those of clinically healthy animals only for benign neoplasms. The balancing of coagulation and fibrinolytic mechanisms was accompanied by a decrease in the activity of proteolytic inhibitors: α2-macroglobulin in experimental groups with benign neoplasia by day 10, malignant – by days 10–14, and control – respectively, by days 3 and 14; α1-proteinase inhibitor in all groups by day 3. Concentration of nitric oxide after extirpation of benign tumors already at day 3 of the postoperative period in all groups corresponded to the indexes of clinically healthy dogs, with the removal of malignant tumours – in experimental animals at day 3, control – at day 14. The content of malondialdehyde and ceruloplasmin against the background of pharmacological correction was restored by days 10–14, whereas in control animals – only with benign neoplasms by day 14. Postoperative pharmacological correction of the hemostasis system can significantly improve the results of treatment in cancer patients.
Highlights
Among the surgical pathologies of small domestic animals, neoplasia is attracting interest from researchers due to the significant increase in registration and inadequate efficacy in treatment of such cases
The objective of the study is to assess the effectiveness of pharmacological correction of hemostasic systems, which follows the electrocoagulation of mammary tumours of female dogs
Monitoring research included a survey of 10,118 dogs, including 1,063 cancer patients with various clinical and pathomorphological forms of mammary gland neoplasia
Summary
Among the surgical pathologies of small domestic animals, neoplasia is attracting interest from researchers due to the significant increase in registration and inadequate efficacy in treatment of such cases. This situation is related to the increase in the population of small domestic animals, an increase in the unfavourable impact of the environment, the broad use of hormone preparations and high level of metastasis and recurrence. The difficulty in solving the problem of increasing the effectiveness of therapeutic measures against neoplasia of the mammary gland is caused by the absence of a unified statistical basis, discussion of the pathogenetic mechanisms of this process and low efficiency of early diagnosis, which does not allow one to form the complete chain of formation, development and subsequent behaviour of the tumour source. Different methods of collecting and assessing create obstacles for the analysis of available information (Brønden et al, 2007)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
